Association of C-reactive protein, interleukin-1 receptor antagonist and adiponectin with the metabolic syndrome

被引:23
作者
Saltevo, Juha [1 ]
Vanhala, Mauno [2 ,3 ]
Kautiainen, Hannu [4 ]
Kumpusalo, Esko [5 ,6 ]
Laakso, Markku [7 ]
机构
[1] Ctr Hosp Middle Finland, Dept Internal Med, Jyvaskyla 40620, Finland
[2] Ctr Hosp Middle Finland, Dept Gen Med, Jyvaskyla 40620, Finland
[3] Laukaa Hlth Ctr, Laukaa 41341, Finland
[4] Medcare Fdn, Aanekoski 44100, Finland
[5] Univ Kuopio, Dept Publ Hlth & Clin Nutr, FIN-70211 Kuopio, Finland
[6] Kuopio Univ Hosp, Unit Gen Practice, Kuopio 70211, Finland
[7] Univ Kuopio, Dept Med, FIN-70211 Kuopio, Finland
关键词
D O I
10.1155/2007/93573
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
This Finnish population-based study, mean age 46 years, evaluates the association of high-sensitivity C-reactive protein (hs-CRP), interleukin-1 receptor antagonist (IL-1Ra), and adiponectin with the NCEP and IDF definitions of metabolic syndrome (MetS). Adiponectin levels were higher, hs-CRP and IL-1Ra levels lower in subjects without MetS compared to subjects with MetS. If MetS was present according to both IDF and NCEP criteria, BMI, waist, triglycerides, hs-CRP, and IL-1Ra were significantly higher compared to subjects who had MetS according to either only IDF or only NCEP criteria. The hs-CRP, IL-1Ra, and adiponectin linearly correlated with the number of the components of MetS according to both definitions. Decreased levels of adiponectin and increased levels of hs-CRP and IL-1Ra are tightly associated with the components of MetS. Individuals who had MetS according to both criteria had the most adverse changes in cardiovascular risk factors. Copyright (c) 2007 Juha Saltevo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
引用
收藏
页数:8
相关论文
共 43 条
[1]  
Adam Fabiola M S, 2006, Acta Med Indones, V38, P179
[2]   The metabolic syndrome - a new worldwide definition [J].
Alberti, KGMM ;
Zimmet, P ;
Shaw, J .
LANCET, 2005, 366 (9491) :1059-1062
[3]  
[Anonymous], 992 WHO
[4]   Physiologic role of interleukin-1 receptor antagonist [J].
Arend, WP ;
Gabay, C .
ARTHRITIS RESEARCH, 2000, 2 (04) :245-248
[5]   Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men [J].
Banerji, MA ;
Faridi, N ;
Atluri, R ;
Chaiken, RL ;
Lebovitz, HE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (01) :137-144
[6]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[7]   Abdominal obesity:: the most prevalent cause of the metabolic syndrome and related cardiometabolic risk [J].
Després, JP .
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2006, 8 (0B) :B4-B12
[8]   Chronic subclinical inflammation as part of the insulin resistance syndrome -: The Insulin Resistance Atherosclerosis Study (IRAS) [J].
Festa, A ;
D'Agostino, R ;
Howard, G ;
Mykkänen, L ;
Tracy, RP ;
Haffner, SM .
CIRCULATION, 2000, 102 (01) :42-47
[9]   Mechanisms of disease: Acute-phase proteins and other systemic responses to inflammation [J].
Gabay, C ;
Kushner, I .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (06) :448-454
[10]   Definition of metabolic syndrome - Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition [J].
Grundy, SM ;
Brewer, HB ;
Cleeman, JI ;
Smith, SC ;
Lenfant, C .
CIRCULATION, 2004, 109 (03) :433-438